NeoGenomics Inc. (NEO)
NeoGenomics Statistics
Share Statistics
NeoGenomics has 25.73M shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 25.73M |
| Shares Change (YoY) | 0.59% |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | 96.83% |
| Shares Floating | 25.42M |
| Failed to Deliver (FTD) Shares | 640 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 4.98M, so 3.88% of the outstanding shares have been sold short.
| Short Interest | 4.98M |
| Short % of Shares Out | 3.88% |
| Short % of Float | 5.38% |
| Short Ratio (days to cover) | 2.4 |
Valuation Ratios
The PE ratio is -5.3 and the forward PE ratio is 18.19. NeoGenomics's PEG ratio is 0.46.
| PE Ratio | -5.3 |
| Forward PE | 18.19 |
| PS Ratio | 0.63 |
| Forward PS | 0.2 |
| PB Ratio | 0.46 |
| P/FCF Ratio | -12.26 |
| PEG Ratio | 0.46 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NeoGenomics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.98 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | -400.62 |
| Debt / FCF | -17.78 |
| Interest Coverage | -13.92 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $300.26K |
| Profits Per Employee | $-35.78K |
| Employee Count | 2,200 |
| Asset Turnover | 0.4 |
| Inventory Turnover | 13.85 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -54.37% in the last 52 weeks. The beta is 1.41, so NeoGenomics's price volatility has been higher than the market average.
| Beta | 1.41 |
| 52-Week Price Change | -54.37% |
| 50-Day Moving Average | 9.72 |
| 200-Day Moving Average | 14.06 |
| Relative Strength Index (RSI) | 25.98 |
| Average Volume (20 Days) | 1.69M |
Income Statement
In the last 12 months, NeoGenomics had revenue of 660.57M and earned -78.73M in profits. Earnings per share was -3.1.
| Revenue | 660.57M |
| Gross Profit | 290.1M |
| Operating Income | -92.11M |
| Net Income | -78.73M |
| EBITDA | -1.51M |
| EBIT | -74.06M |
| Earnings Per Share (EPS) | -3.1 |
Balance Sheet
The company has 367.01M in cash and 605.33M in debt, giving a net cash position of -238.32M.
| Cash & Cash Equivalents | 367.01M |
| Total Debt | 605.33M |
| Net Cash | -238.32M |
| Retained Earnings | -325.78M |
| Total Assets | 1.64B |
| Working Capital | 294.78M |
Cash Flow
In the last 12 months, operating cash flow was 7.02M and capital expenditures -41.06M, giving a free cash flow of -34.04M.
| Operating Cash Flow | 7.02M |
| Capital Expenditures | -41.06M |
| Free Cash Flow | -34.04M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 43.92%, with operating and profit margins of -13.94% and -11.92%.
| Gross Margin | 43.92% |
| Operating Margin | -13.94% |
| Pretax Margin | -11.92% |
| Profit Margin | -11.92% |
| EBITDA Margin | -0.23% |
| EBIT Margin | -13.94% |
| FCF Margin | -5.15% |
Dividends & Yields
NEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for NEO is $18.5, which is 190.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.5 |
| Price Target Difference | 190.4% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Stock Splits
The last stock split was on Apr 16, 2003. It was a backward split with a ratio of 1:100.
| Last Split Date | Apr 16, 2003 |
| Split Type | backward |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | 0.68 |
| Piotroski F-Score | 4 |